| Systems vaccinology of the BNT162b2 mRNA vaccine in humans PS Arunachalam, MKD Scott, T Hagan, C Li, Y Feng, F Wimmers, ... Nature 596 (7872), 410-416, 2021 | 467 | 2021 |
| Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination K Röltgen, SCA Nielsen, O Silva, SF Younes, M Zaslavsky, C Costales, ... Cell 185 (6), 1025-1040. e14, 2022 | 433 | 2022 |
| Epicutaneous sensitization in the development of food allergy: what is the evidence and how can this be prevented? HA Brough, KC Nadeau, SB Sindher, SS Alkotob, S Chan, HT Bahnson, ... Allergy 75 (9), 2185-2205, 2020 | 240 | 2020 |
| Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study SM Jones, EH Kim, KC Nadeau, A Nowak-Wegrzyn, RA Wood, ... The Lancet 399 (10322), 359-371, 2022 | 212 | 2022 |
| Phase 2a randomized, placebo-controlled study of anti–IL-33 in peanut allergy S Chinthrajah, S Cao, C Liu, SC Lyu, SB Sindher, A Long, V Sampath, ... JCI insight 4 (22), e131347, 2019 | 173 | 2019 |
| Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system CM Warren, TT Snow, AS Lee, MM Shah, A Heider, A Blomkalns, B Betts, ... JAMA network open 4 (9), e2125524-e2125524, 2021 | 133 | 2021 |
| Omalizumab for the treatment of multiple food allergies RA Wood, A Togias, SH Sicherer, WG Shreffler, EH Kim, SM Jones, ... New England Journal of Medicine 390 (10), 889-899, 2024 | 131 | 2024 |
| Climate change and global health: a call to more research and more action I Agache, V Sampath, J Aguilera, CA Akdis, M Akdis, M Barry, ... Allergy 77 (5), 1389-1407, 2022 | 125 | 2022 |
| Phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy M Greenhawt, SB Sindher, J Wang, M O’Sullivan, G Du Toit, EH Kim, ... New England Journal of Medicine 388 (19), 1755-1766, 2023 | 77 | 2023 |
| Continuous and daily oral immunotherapy for peanut allergy: results from a 2-year open-label follow-on study BP Vickery, A Vereda, C Nilsson, G du Toit, WG Shreffler, AW Burks, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (5), 1879-1889 …, 2021 | 77 | 2021 |
| Asthma phenotypes, associated comorbidities, and long‐term symptoms in COVID‐19 LE Eggert, Z He, W Collins, AS Lee, G Dhondalay, SY Jiang, J Fitzpatrick, ... Allergy 77 (1), 173-185, 2022 | 76 | 2022 |
| Early intervention and prevention of allergic diseases HA Brough, BJ Lanser, SB Sindher, JMC Teng, DYM Leung, C Venter, ... Allergy 77 (2), 416-441, 2022 | 65 | 2022 |
| Can food allergy be cured? What are the future prospects? V Sampath, SB Sindher, AM Alvarez Pinzon, KC Nadeau Allergy 75 (6), 1316-1326, 2020 | 65 | 2020 |
| Food allergy, mechanisms, diagnosis and treatment: innovation through a multi‐targeted approach SB Sindher, A Long, AR Chin, A Hy, V Sampath, KC Nadeau, ... Allergy 77 (10), 2937-2948, 2022 | 63 | 2022 |
| Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection F Gao, V Mallajosyula, PS Arunachalam, K van der Ploeg, M Manohar, ... Immunity 56 (4), 864-878. e4, 2023 | 59* | 2023 |
| Eliciting dose and safety outcomes from a large dataset of standardized multiple food challenges N Purington, RS Chinthrajah, A Long, S Sindher, S Andorf, K O'Laughlin, ... Frontiers in immunology 9, 2057, 2018 | 57 | 2018 |
| New treatment directions in food allergy V Sampath, SB Sindher, W Zhang, KC Nadeau Annals of Allergy, Asthma & Immunology 120 (3), 254-262, 2018 | 52 | 2018 |
| Gastrointestinal eosinophil responses in a longitudinal, randomized trial of peanut oral immunotherapy BL Wright, NQ Fernandez-Becker, N Kambham, N Purington, S Cao, ... Clinical Gastroenterology and Hepatology 19 (6), 1151-1159. e14, 2021 | 50 | 2021 |
| The use of biomarkers to predict aero-allergen and food immunotherapy responses SB Sindher, A Long, S Acharya, V Sampath, KC Nadeau Clinical reviews in allergy & immunology 55, 190-204, 2018 | 50 | 2018 |
| Safety of epicutaneous immunotherapy in peanut-allergic children: REALISE randomized clinical trial results JA Pongracic, R Gagnon, G Sussman, D Siri, RC Oriel, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (7), 1864 …, 2022 | 47 | 2022 |
